Patrizia Perri

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Transcription Factor

Acute Lymphoblastic Leukemia

Long Noncoding Rna

Top Venues

Journal of experimental & clinical cancer research : CR

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fabio Pastorino, Mario Capasso, Chiara Brignole, Vito Alessandro Lasorsa, Veronica Bensa, Patrizia Perri, Sueva Cantalupo, Serena Giglio, Massimo Provenzi, Marco Rabusin, Elvira Pota, Monica Cellini, Annalisa Tondo, Maria Antonietta De Ioris, Angela R Sementa, Alberto Garaventa, Mirco Ponzoni, Loredana Amoroso
Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology. Cancers 15 (3) (2023)
Fabio Pastorino, Mario Capasso, Chiara Brignole, Vito Alessandro Lasorsa, Veronica Bensa, Patrizia Perri, Sueva Cantalupo, Serena Giglio, Massimo Provenzi, Marco Rabusin, Elvira Pota, Monica Cellini, Annalisa Tondo, Maria Antonietta De Ioris, Angela R Sementa, Alberto Garaventa, Mirco Ponzoni, Loredana Amoroso
Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology. Cancers 15 (3) (2023)
Mirco Ponzoni, Tiziana Bachetti, Maria Valeria Corrias, Chiara Brignole, Fabio Pastorino, Enzo Calarco, Veronica Bensa, Elena Giusto, Isabella Ceccherini, Patrizia Perri
Recent advances in the developmental origin of neuroblastoma: an overview. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Massimo Moro, Orazio Fortunato, Giulia Bertolini, Mavis Mensah, Cristina Borzi, Giovanni Centonze, Francesca Andriani, Daniela Di Paolo, Patrizia Perri, Mirco Ponzoni, Ugo Pastorino, Gabriella Sozzi, Mattia Boeri
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Barbara Marengo, Alessandra Pulliero, Maria Valeria Corrias, Riccardo Leardi, Emanuele Farinini, Gilberto Fronza, Paola Menichini, Paola Menichini, Lorenzo Monteleone, Giulia Elda Valenti, Andrea Speciale, Patrizia Perri, Francesca Madia, Alberto Izzotti, Cinzia Domenicotti
Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma. Journal of personalized medicine 11 (2) (2021)
Fabio Morandi, Veronica Bensa, Enzo Calarco, Fabio Pastorino, Patrizia Perri, Maria Valeria Corrias, Mirco Ponzoni, Chiara Brignole
The Olive Leaves Extract Has Anti-Tumor Effects against Neuroblastoma through Inhibition of Cell Proliferation and Induction of Apoptosis. Nutrients 13 (7) (2021)
Chiara Brignole, Fabio Pastorino, Patrizia Perri, Loredana Amoroso, Veronica Bensa, Enzo Calarco, Mirco Ponzoni, Maria Valeria Corrias
Bone Marrow Environment in Metastatic Neuroblastoma. Cancers 13 (10) (2021)
Patrizia Perri, Mirco Ponzoni, Maria Valeria Corrias, Isabella Ceccherini, Simona Candiani, Tiziana Bachetti
A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma. Cancers 13 (21) (2021)
Adriana Agnese Amaro, Michela Croce, Silvano Ferrini, Gaia Barisione, Marina Gualco, Patrizia Perri, Ulrich Pfeffer, Martine J Jager, Sarah E Coupland, Carlo Mosci, Gilberto Filaci, Marina Fabbi, Paola Queirolo, Rosaria Gangemi
Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition. Cancers 12 (6) (2020)
Daniela Di Paolo, Fabio Pastorino, Chiara Brignole, Maria Valeria Corrias, Laura Emionite, Michele Cilli, Roberto Tamma, Leslie Priddy, Adriana Amaro, Davide Ferrari, Roberto Marotta, Elisa Ferretti, Ulrich Pfeffer, Domenico Ribatti, Angela Rita Sementa, David Brown, Naohiko Ikegaki, Hiroyuki Shimada, Mirco Ponzoni, Patrizia Perri
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models. Small (Weinheim an der Bergstrasse, Germany) 16 (20) (2020)
Mirco Ponzoni, Fabio Pastorino, Daniela Di Paolo, Patrizia Perri, Chiara Brignole
Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer. International journal of molecular sciences 19 (7) (2018)